NCT00077844已完成2 期
An International Phase 2-3, Stratified, Randomized, Open-label, Parallel-group Clinical Trial to Evaluate the Safety and Efficacy of a Single Intravenous Bolus of Enoxaparin Versus Intravenous Unfractionated Heparin in Patients Undergoing Non-emergent Percutaneous Coronary Intervention
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- Sanofi
- 入组人数
- 3,532
- 主要终点
- the composite of non-CABG major and minor bleeding
研究概览
简要总结
The purpose of this study is to evaluate the efficacy and safety of intravenous enoxaparin versus intravenous unfractionated heparin (UFH) in patients undergoing non-emergent PCI, as assessed by measuring the incidence of non-coronary artery bypass graft (CABG) major and minor bleeding.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
the composite of non-CABG major and minor bleeding
时间窗: up to H48 after index PCI
次要结局
- success rate of achieving ACT target range(at the beginning and end of procedure)
研究者
相似试验
已完成
4 期
Enoxaparin Versus Unfractionated Heparin in Subjects Who Present to the Emergency Department With Acute Coronary Syndrome (RESCUE)Acute Coronary SyndromeNCT00077818Sanofi
已完成
3 期
Enoxaparin at Prophylactic or Therapeutic Doses in COVID-19Covid19ThrombosisNCT04646655ASST Fatebenefratelli Sacco142
终止
不适用
Enoxaparin and/or Minocycline in Acute StrokeAcute Ischemic StrokeNCT00836355NYU Langone Health6
已完成
4 期
The Effect of Vasopressors on the Anti Xa Response to Enoxaparin in Critically Ill PatientsCritical IllnessVenous ThrombosisNCT00351663Shaare Zedek Medical Center39
终止
4 期
Ischemia Driven Enoxaparin Therapy in ACS Presenting as Low Risk (IDEAL)Unstable AnginaNCT00518245Canadian Heart Research Centre11